AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$3,962
-9.02%
Shares
Shares Volume: 2,957 Shares
Average Share Price: $1.34
INSIDER
Chanda Sanjay
Chief Development Officer (Officer)
reported on Jan 7 2025
traded on Jan 3 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 29,824 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $3,962.38 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 7 / 12 |
| P/S VALUE RATIO | 0.207 |
| AVERAGE SALE VALUE | $827,399.37 |
| COMPANY PREVIOUS TRADES |